We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Community Health Systems
CYH
$393M
| $1.84M | ﹤0.01% |
207,447
+64,082
| +45% | +$500K |
|
|
IPXL
1602
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.84M | ﹤0.01% |
145,324
+38,227
| +36% | +$462K |
|
|
MTOR
1603
DELISTED
MERITOR, Inc.
MTOR
| $1.83M | ﹤0.01% |
107,069
+1,068
| +1% | +$16.5K |
|
|
MSGN
1604
DELISTED
MSG Networks Inc.
MSGN
| $1.83M | ﹤0.01% |
78,412
+2,131
| +3% | +$47.7K |
|
1605
Acco Brands
ACCO
$389M
| $1.83M | ﹤0.01% |
139,166
+5,019
| +4% | +$65.2K |
|
|
FCB
1606
DELISTED
FCB Financial Holdings, Inc.
FCB
| $1.83M | ﹤0.01% |
36,942
+1,910
| +5% | +$91.2K |
|
1607
Archrock
AROC
$6.27B
| $1.83M | ﹤0.01% |
147,369
+39,239
| +36% | +$551K |
|
1608
WSFS Financial
WSFS
$4.12B
| $1.83M | ﹤0.01% |
39,728
+1,590
| +4% | +$72.2K |
|
1609
Otter Tail
OTTR
$3.71B
| $1.82M | ﹤0.01% |
48,045
-627
| -1% | -$23.7K |
|
1610
MaxLinear
MXL
$6.06B
| $1.82M | ﹤0.01% |
64,759
+2,442
| +4% | +$62.6K |
|
|
LABL
1611
DELISTED
Multi-Color Corp
LABL
| $1.82M | ﹤0.01% |
25,581
+7,290
| +40% | +$543K |
|
1612
National Bank Holdings
NBHC
$1.92B
| $1.81M | ﹤0.01% |
55,812
+14,695
| +36% | +$473K |
|
|
CVGW
1613
DELISTED
Calavo Growers
CVGW
| $1.81M | ﹤0.01% |
29,832
+9,007
| +43% | +$520K |
|
|
UHT
1614
Universal Health Realty Income Trust
UHT
$603M
| $1.81M | ﹤0.01% |
28,011
+7,809
| +39% | +$494K |
|
|
USCR
1615
DELISTED
U S Concrete, Inc.
USCR
| $1.81M | ﹤0.01% |
27,995
+8,399
| +43% | +$543K |
|
|
CRAY
1616
DELISTED
Cray, Inc.
CRAY
| $1.81M | ﹤0.01% |
82,518
+23,562
| +40% | +$465K |
|
1617
Heartland Express
HTLD
$948M
| $1.8M | ﹤0.01% |
90,028
-7,874
| -8% | -$160K |
|
1618
Lakeland Financial Corp
LKFN
$1.56B
| $1.8M | ﹤0.01% |
41,806
-3,181
| -7% | -$142K |
|
1619
Penske Automotive Group
PAG
$14.3B
| $1.8M | ﹤0.01% |
38,526
+2,483
| +7% | +$127K |
|
1620
Zillow
ZG
$7.94B
| $1.8M | ﹤0.01% |
53,261
+1,617
| +3% | +$57.6K |
|
|
MANT
1621
DELISTED
Mantech International Corp
MANT
| $1.79M | ﹤0.01% |
51,778
+14,163
| +38% | +$540K |
|
1622
McGrath RentCorp
MGRC
$2.81B
| $1.79M | ﹤0.01% |
53,365
+18,065
| +51% | +$659K |
|
|
SWFT
1623
DELISTED
Swift Transportation Company
SWFT
| $1.79M | ﹤0.01% |
87,072
+1,054
| +1% | +$23.5K |
|
1624
MACOM Technology Solutions
MTSI
$19.2B
| $1.78M | ﹤0.01% |
36,941
+10,739
| +41% | +$502K |
|
|
EPAY
1625
DELISTED
Bottomline Technologies Inc
EPAY
| $1.78M | ﹤0.01% |
75,421
+20,039
| +36% | +$505K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.